303 related articles for article (PubMed ID: 21826656)
21. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.
Luo H; Zou J; Dong Z; Zeng Q; Wu D; Liu L
Biochem J; 2012 Mar; 442(2):311-21. PubMed ID: 22132820
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
[TBL] [Abstract][Full Text] [Related]
23. BCR-ABL affects STAT5A and STAT5B differentially.
Schaller-Schönitz M; Barzan D; Williamson AJ; Griffiths JR; Dallmann I; Battmer K; Ganser A; Whetton AD; Scherr M; Eder M
PLoS One; 2014; 9(5):e97243. PubMed ID: 24836440
[TBL] [Abstract][Full Text] [Related]
24. The significance of PITX2 overexpression in human colorectal cancer.
Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
26. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
Xi S; Zhang Q; Gooding WE; Smithgall TE; Grandis JR
Cancer Res; 2003 Oct; 63(20):6763-71. PubMed ID: 14583472
[TBL] [Abstract][Full Text] [Related]
27. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
28. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.
Sagiv E; Memeo L; Karin A; Kazanov D; Jacob-Hirsch J; Mansukhani M; Rechavi G; Hibshoosh H; Arber N
Gastroenterology; 2006 Aug; 131(2):630-9. PubMed ID: 16890615
[TBL] [Abstract][Full Text] [Related]
29. STAT5A and STAT5B have opposite correlations with drug response gene expression.
Lamba V; Jia B; Liang F
Biochem Biophys Res Commun; 2016 Oct; 479(2):117-124. PubMed ID: 27264955
[TBL] [Abstract][Full Text] [Related]
30. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
31. Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells.
Kazansky AV; Rosen JM
Cell Growth Differ; 2001 Jan; 12(1):1-7. PubMed ID: 11205741
[TBL] [Abstract][Full Text] [Related]
32. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
[TBL] [Abstract][Full Text] [Related]
33. Aberrant methylation of the Pleckstrin and Sec7 domain-containing gene is implicated in ulcerative colitis-associated carcinogenesis through its inhibitory effect on apoptosis.
Okada S; Suzuki K; Takaharu K; Noda H; Kamiyama H; Maeda T; Saito M; Koizumi K; Miyaki Y; Konishi F
Int J Oncol; 2012 Mar; 40(3):686-94. PubMed ID: 22002136
[TBL] [Abstract][Full Text] [Related]
34. FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.
Mimori K; Ishii H; Nagahara H; Sudo T; Yamashita K; Inoue H; Barnard GF; Mori M
Cancer Res; 2006 Mar; 66(5):2683-90. PubMed ID: 16510588
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas.
Mumtaz M; Wågsäter D; Löfgren S; Hugander A; Zar N; Dimberg J
Oncol Rep; 2009 Jan; 21(1):153-8. PubMed ID: 19082456
[TBL] [Abstract][Full Text] [Related]
36. STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression.
Zhang Q; Wang HY; Liu X; Wasik MA
Nat Med; 2007 Nov; 13(11):1341-8. PubMed ID: 17922009
[TBL] [Abstract][Full Text] [Related]
37. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
38. Activation of the serine/threonine protein kinase AKT during the progression of colorectal neoplasia.
Saglam O; Garrett CR; Boulware D; Sayegh Z; Shibata D; Malafa M; Yeatman T; Cheng JQ; Sebti S; Coppola D
Clin Colorectal Cancer; 2007 Sep; 6(9):652-6. PubMed ID: 17945038
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of aminoacylase 1 is associated with colorectal cancer progression.
Shi H; Hayes MT; Kirana C; Miller RJ; Keating JP; Stubbs RS
Hum Pathol; 2013 Jun; 44(6):1089-97. PubMed ID: 23317546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
